These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3053796)

  • 21. [Potentiation of antidepressive treatment by thyroid hormone therapy. Review of the literature].
    Verdoux H; Peyre F; Bourgeois M
    Encephale; 1989; 15(6):517-22. PubMed ID: 2693072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressant drug therapy in the elderly--a critical review of the controlled clinical trials conducted since 1980.
    Volz HP; Möller HJ
    Pharmacopsychiatry; 1994 May; 27(3):93-100. PubMed ID: 8078956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome criteria in antidepressant drug trials: self-rating versus observer-rating scales.
    Möller HJ
    Pharmacopsychiatry; 1991 May; 24(3):71-5. PubMed ID: 1891483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antidepressant drugs].
    Aguiar CC; Castro TR; Carvalho AF; Vale OC; Sousa FC; Vasconcelos SM
    Acta Med Port; 2011; 24(1):91-8. PubMed ID: 21672446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for shortening the duration of clinical trials of antidepressants and a proposed paradigm for such studies.
    Katz MM; Berman N; Bowden CL; Frazer A
    J Clin Psychopharmacol; 2015 Jun; 35(3):329-32. PubMed ID: 25874919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternate drugs.
    Adelman AM; Daly MP; Michocki RJ
    Clin Geriatr Med; 1990 May; 6(2):423-44. PubMed ID: 2184932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Problems in the Descriptions of the Psychiatric Inclusion and Exclusion Criteria in Publications of Antidepressant Efficacy Trials: A Qualitative Review and Recommendations for Improved Clarity.
    Zimmerman M; Multach M; Walsh E; Rosenstein LK; Gazarian D; Clark HL
    CNS Drugs; 2016 Mar; 30(3):185-91. PubMed ID: 26818632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drugs: guide and caveats to explanatory and descriptive approaches--II. Drugs in psychiatric research.
    Bollini P; Cotecchia S; De Blasi A; Romandini S; Tognoni G
    J Psychiatr Res; 1984; 18(4):391-400. PubMed ID: 6595401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience and a double-blind study of a new anti-depressant, vivactil hydrochloride.
    Daneman EA
    Psychosomatics; 1965; 6(5):342-6. PubMed ID: 5319247
    [No Abstract]   [Full Text] [Related]  

  • 30. Mental health services research: moving from academia to the community.
    Callahan CM; Hendrie HC
    Am J Geriatr Psychiatry; 2010 Jun; 18(6):460-3. PubMed ID: 21217557
    [No Abstract]   [Full Text] [Related]  

  • 31. Geriatric psychopharmacology.
    Small GW
    West J Med; 1989 Sep; 151(3):312-3. PubMed ID: 18750637
    [No Abstract]   [Full Text] [Related]  

  • 32. Retrospective cohort study of venlafaxine, fluoxetine or sertraline in long-term care.
    Blake LM; Wan GJ; Panish JM; Buatti MC
    Clin Drug Investig; 2003; 23(11):735-42. PubMed ID: 17536887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unipolar late-onset depression: A comprehensive review.
    Fountoulakis KN; O'Hara R; Iacovides A; Camilleri CP; Kaprinis S; Kaprinis G; Yesavage J
    Ann Gen Hosp Psychiatry; 2003 Dec; 2(1):11. PubMed ID: 14675492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressants in the elderly: challenges for study design and their interpretation.
    Parikh C
    Br J Clin Pharmacol; 2000 Jun; 49(6):539-47. PubMed ID: 10848717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choosing appropriate antidepressant therapy in the elderly. A risk-benefit assessment of available agents.
    Flint AJ
    Drugs Aging; 1998 Oct; 13(4):269-80. PubMed ID: 9805208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers.
    Ronfeld RA; Tremaine LM; Wilner KD
    Clin Pharmacokinet; 1997; 32 Suppl 1():22-30. PubMed ID: 9068932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacokinetics of antidepressants in the elderly. Therapeutic implications.
    von Moltke LL; Greenblatt DJ; Shader RI
    Clin Pharmacokinet; 1993 Feb; 24(2):141-60. PubMed ID: 8471078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychotropic drugs, aging and community care.
    Philpot M; Puranik A
    Drugs Aging; 1994 Oct; 5(4):235-41. PubMed ID: 7827394
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of antidepressants on cognitive functioning of elderly patients. A review.
    Knegtering H; Eijck M; Huijsman A
    Drugs Aging; 1994 Sep; 5(3):192-9. PubMed ID: 7803947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Problems and pitfalls in the use of benzodiazepines in the elderly.
    Kruse WH
    Drug Saf; 1990; 5(5):328-44. PubMed ID: 2222867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.